Opioid Overdose Treatment Market

Opioid Overdose Treatment Market Outlook (2024 to 2034)

The global opioid overdose treatment market is valued at US$ 1.54 billion in 2024, as revealed in a newly published report by Fact.MR. Over the assessment period (2024 to 2034), the market is forecasted to advance at a CAGR of 7.2% and reach a US$ 3.1 billion by the end of 2034.

Overdose of opioids can be fatal because of its adverse effects on the brain, which works for regulating breathing. Difficulties in breathing, unconsciousness, and pinpoint pupils are some of the symptoms witnessed during an opioid overdose. Growing incidence of opioid overdose around the world is attributed to its excessive consumption to manage chronic pain.

Geriatric people, males, and individuals with comparatively low socio-economic conditions are comparatively at a higher risk of opioid overdose compared to the female population, people of high socio-economic condition, and people of young age. Timely administration of drugs and basic life support help in the reversal of opioid overdose, which is driving market players to come up with more effective treatment solutions.

• Worldwide demand for opioid antagonists is evaluated to increase at a CAGR of 7.8% and reach a market value of US$ 1.06 billion by 2034-end.
• Global sales of naloxone are analyzed to rise at 8.6% CAGR and reach US$ 1.11 billion by 2034.
• Prescription (Rx)-based sales of opioid overdose treatment solutions are approximated to accelerate at a CAGR of 7.2% and reach US$ 2.71 billion by the end of 2034.
• The market in South Korea is projected to advance at 7.8% CAGR from 2024 to 2034.
• Demand for opioid overdose treatment in Canada is projected to accelerate at a CAGR of 9.8% through 2034.

Report Attribute	Detail
Opioid Overdose Treatment Market Size (2024E)	US$ 1.54 Billion
Forecasted Market Value (2034F)	US$ 3.1 Billion
Global Market Growth Rate (2024 to 2034)	7.2% CAGR
Market Share of Rehabilitation Centers (2034F)	29.7%
North America Market Share (2034F)	43.9%
India Market Growth Rate (2024 to 2034)	11.2% CAGR
Key Companies Profiled	Amneal Pharmaceuticals; Astellas Pharma; AstraZeneca; Bayer; Biotoscana; Collegium Pharmaceutical; EMS Pharma; Endo International; Ethypharm; Eurofarma; GlaxoSmithKline; Hikma Pharmaceuticals; Johnson & Johnson; Mallinckrodt Pharmaceuticals; Mundipharma; Mylan; Novartis; Pfizer; Purdue Pharma; Sanofi; Stada Arzneimittel; Takeda; Teva Pharmaceuticals.

Why is the Opioid Overdose Treatment Market Size Expanding at a Brisk Pace?

“Adverse Impacts of Opioid Overdose Leading to Life-Threatening Incidents”

An opioid overdose, in combination with several other substances, such as sedatives, alcohol, or stimulants, occurs when opioids adversely affect part of the human brain that regulates breathing. Unconsciousness or unresponsiveness, shallowness, stopped or slowed breathing, pinpoint pupils, cold or clammy skin, gurgling or snoring sounds from the mouth, and blue lips are some of the symptoms of an opioid overdose. These issues lead to ineffective breathing issues, and in severe cases, even death. A person experiencing an opioid overdose requires naloxone and immediate healthcare to prevent critical health issues.

What is a Critical Issue Faced in This Market Space?

“Limited Options Available for Treatment of Opioid Overdose”

Naloxone is currently used as one of the more effective treatment options against an overdose of opioids. It is used for the reversal of adverse effects of opioids, such as respiratory depression. However, there aren’t many other treatment options, and this limitation has been adversely impacting opioid treatment market growth opportunities.

What is Assisting Startups Increase Their Market Share?

“Investing in R&D Activities to Explore New Treatment Options”

A key opioid overdose treatment market trend is that new companies are investing heavily in R&D activities for the exploration of new treatment options against opioid overdose. This will help them attract a larger base of end users, such as healthcare professionals, to tackle crucial medical situations.

Country-wise Insights

As per this newly published research report by Fact.MR, a market research and competitive intelligence provider, North America is projected to hold 43.9% of the global opioid overdose treatment market share by the end of 2034. High demand for opioid overdose treatment solutions in the region is owing to rising cases of chronic pain and mental health disorders, which is driving the consumption of opioids. People aged around 18 to 45 years are the predominating group experiencing chronic issues, which is generating remunerative opportunities for providers of opioid overdose treatment options.

Why is the United States a Key Market for Opioid Overdose Treatment?

“High Number of Cases of Opioid Overdose in the Country”

Attribute	United States
Market Value (2024E)	US$ 577.1 Million
Growth Rate (2024 to 2034)	7.8% CAGR
Projected Value (2034F)	US$ 1.22 Billion

The United States is forecasted to occupy a market share of 85% in North America by the end of 2034.

• A report ‘Trends and Geographic Patterns in Drug and Synthetic Opioid Overdose Deaths – United States, 2023 - 2019’ was published by Morbidity and Mortality Weekly Report, on February 12, 2021. This report stated that 70,630 people died in the United States of America in 2019 due to drug overdose and approx. half of these deaths involved synthetic opioids.

Such increasing incidents of opioid overdose are resulting in the high requirement for effective treatment solutions to save lives and combat the overdose menace.

What’s Helping Opioid Overdose Treatment Solution Providers in Japan?

“Implementation of Supportive Government Policies”

Attribute	Japan
Market Value (2024E)	US$ 70.5 Million
Growth Rate (2024 to 2034)	2.8% CAGR
Projected Value (2034F)	US$ 93.2 Million

Japan is evaluated to hold 20.3% share of the East Asian market revenue by the end of 2034. The government in Japan takes healthcare seriously and has laid down several regulations concerning opioid medications. This is driving the development of medications required for treating opioid overdose in the country.

Category-wise Insights

Global demand for prescription-based opioid overdose treatment solutions is forecasted to increase at a CAGR of 7.2% and reach a market valuation of US$ 2.71 billion by the end of 2034. Growing prominence for these modes of sales is attributed to the safety, trust, and authenticity associated with the medications offered.

Which Drug Class is Popular for Opioid Overdose Treatment?

“Assistance of Antagonists in Effectively Blocking Effects of Opioids”

Attribute	Opioid Antagonists
Segment Value (2024E)	US$ 502.2 Million
Growth Rate (2024 to 2034)	7.8% CAGR
Projected Value (2034F)	US$ 1.06 Billion

The opioid antagonist drug class is projected to account for 34.3% share of the global market by 2034. These drugs are used to block the effects of some common opioids, where naltrexone is highly popular. They help in the treatment of opioid overdose. In addition, their assistance in treating opioid use disorders, opioid-induced constipation, and alcohol disorders is contributing to increased demand among healthcare providers around the world.

Which Opioid Overdose Treatment Drugs Have Gained Prominence?

“Increasing Consumption of Naloxone for Effectively Destroying Opioids”

Attribute	Naloxone
Market Value (2024E)	US$ 489.5 Million
Growth Rate (2024 to 2034)	8.6% CAGR
Projected Value (2034F)	US$ 1.11 Billion

Naloxone is approximated to contribute 36% share of global market revenue by the end of 2034. This is an FDA (Food & Drug Administration)-approved antidote that is used for the reversal and blocking effects caused due to the overdose of opioids such as oxycodone, morphine, and heroin. Growing demand for naloxone is attributed to its ability to find opioids and then rip them off and block the same.

Which End User Accounts for High Revenue Generation?

“High Demand for Opioid Overdose Treatment Solutions in Rehabilitation Centers”

Attribute	Rehabilitation Centers
Segment Value (2024E)	US$ 460.1 Million
Growth Rate (2024 to 2034)	7.2% CAGR
Projected Value (2034F)	US$ 920.5 Million

Rehabilitation centers are analyzed to account for a share of 29.7% of the global market by 2034. High demand for opioid overdose treatment solutions in rehabilitation centers for opioid overdose, such as buprenorphine or methadone, is creating remunerative opportunities for market players globally. They are utilized at these centers for opioid agonist withdrawal management and maintenance therapy.

Competitive Landscape

Key players in the opioid overdose treatment industry are looking to develop more advanced and effective treatment solutions to ensure efficiency in outcomes.

For instance:

• Naloxone HCI Nasal Spray of Amneal got approval from the United States FDA in April 2024. This is a widely used spray that helps in the treatment of opioid drug overdose.

Fact.MR provides detailed information about the price points of key players in the opioid overdose treatment market positioned across the world, sales growth, production capacity, and speculative technological expansion, in this newly published market report.

Segmentation of Opioid Overdose Treatment Market Research

• By Drug Class :

  • Opioid Antagonists
  • Partial Agonists
  • Full Agonists
  • Combination Drugs
  • Supportive Medications
  • Others

• By Drug :

  • Naloxone
  • Buprenorphine
  • Methadone
  • Naltrexone
  • Lofexidine
  • Extended-release Buprenorphine
  • Extended-release Naltrexone
  • Buprenorphine Implant
  • Buprenorphine Buccal Film
  • Other Drugs

• By Mode of Sale :

  • Prescription (Rx)
  • Over-the-Counter (OTC)

• By End User :

  • Hospitals
  • Emergency Departments
  • Rehabilitation Centers
  • Outpatient Clinics
  • Community Health Centers
  • Others

• By Region :

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • East Asia
  • South Asia & Pacific
  • MEA